An engineered human antibody to TNF (CDP571) for active Crohn's disease: a randomized double-blind placebo-controlled trial.
Sandborn WJ, Feagan BG, Hanauer SB, Present DH, Sutherland LR, Kamm MA, Wolf DC, Baker JP, Hawkey C, Archambault A, Bernstein CN, Novak C, Heath PK, Targan SR; CDP571 Crohn's Disease Study Group.
Sandborn WJ, et al.
Gastroenterology. 2001 May;120(6):1330-8. doi: 10.1053/gast.2001.24042.
Gastroenterology. 2001.
PMID: 11313302
Clinical Trial.